EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer’s disease through a systems biology approach and drug repurposing

Zahra Azizan, Hakimeh Zali iD, Seyed Amir Mirmotalebisohi, Maryam Bazrgar, Abolhassan Ahmadiani iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Zahra Azizan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Metabolic Syndrome, Drug Repositioning, Protein Interaction Maps. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: shahid Beheshti university of medical sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between Alzheimer’s disease and metabolic disorders as significant risk factors is widely acknowledged. However, the intricate molecular mechanism intertwining these conditions remains elusive. To address this knowledge gap, we conducted a thorough investigation using a bioinformatics method to illuminate the molecular connections and pathways that provide novel perspectives on these disorders’ pathological and clinical features. Microarray datasets (GSE5281, GSE122063) from the Gene Expression Omnibus (GEO) database facilitated the way to identify genes with differential expression in Alzheimer’s disease (141 genes). Leveraging CoreMine, CTD, and Gene Card databases, we extracted genes associated with metabolic conditions, including hypertension, non-alcoholic fatty liver disease, and diabetes. Subsequent analysis uncovered overlapping genes implicated in metabolic conditions and Alzheimer’s disease, revealing shared molecular links. We utilized String and HIPPIE databases to visualize these shared genes’ protein-protein interactions (PPI) and constructed a PPI network using Cytoscape and MCODE plugin. SPP1, CD44, IGF1, and FLT1 were identified as crucial molecules in the main cluster of Alzheimer’s disease and metabolic syndrome. Enrichment analysis by the DAVID dataset was employed and highlighted the SPP1 as a novel target, with its receptor CD44 playing a significant role in the inflammatory cascade and disruption of insulin signaling, contributing to the neurodegenerative aspects of Alzheimer’s disease. ECM-receptor interactions, focal adhesion, and the PI3K/Akt pathways may all mediate these effects. Additionally, we investigated potential medications by repurposing the molecular links using the DGIdb database, revealing Tacrolimus and Calcitonin as promising candidates, particularly since they possess binding sites on the SPP1 molecule. In conclusion, our study unveils crucial molecular bridges between metabolic syndrome and AD, providing insights into their pathophysiology for therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMetabolic SyndromeDrug RepositioningProtein Interaction MapsSystems BiologyHumansGene Regulatory NetworksComputational BiologySignal TransductionDatabases, GeneticGene Expression Profiling

Autor:innen und Institutionen

  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Hakimeh Zali, Abolhassan Ahmadiani

Förderung

  • shahid Beheshti university of medical sciences

Zitieren

APA

Azizan, Z., Zali, H., Mirmotalebisohi, S. A., Bazrgar, M., & Ahmadiani, A. (2024). Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer’s disease through a systems biology approach and drug repurposing. PLOS ONE. https://doi.org/10.1371/journal.pone.0304410

Vancouver

Azizan Z, Zali H, Mirmotalebisohi SA, Bazrgar M, Ahmadiani A. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer’s disease through a systems biology approach and drug repurposing. PLOS ONE. 2024. doi:10.1371/journal.pone.0304410

BibTeX
@article{Azizan2024,
  author = {Azizan, Zahra and Zali, Hakimeh and Mirmotalebisohi, Seyed Amir and Bazrgar, Maryam and Ahmadiani, Abolhassan},
  title = {Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer’s disease through a systems biology approach and drug repurposing},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304410}
}
Kostenlos starten →